Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML.

MLA

Letson, Christopher T., et al. “Targeting BET Proteins Downregulates MiR-33a To Promote Synergy with PIM Inhibitors in CMML.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 15, Aug. 2023, pp. 2919–32. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-22-3929.

APA

Letson, C. T., Balasis, M. E., Newman, H., Binder, M., Vedder, A., Kinose, F., Ball, M., Kruer, T., Quintana, A., Lasho, T. L., Finke, C. M., Almada, L. L., Grants, J. M., Zhang, G., Fernandez-Zapico, M. E., Gaspar-Maia, A., Lancet, J., Komrokji, R., Haura, E., … Padron, E. (2023). Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 29(15), 2919–2932. https://doi.org/10.1158/1078-0432.CCR-22-3929

Chicago

Letson, Christopher T, Maria E Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose, Markus Ball, et al. 2023. “Targeting BET Proteins Downregulates MiR-33a To Promote Synergy with PIM Inhibitors in CMML.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29 (15): 2919–32. doi:10.1158/1078-0432.CCR-22-3929.